Press Releases

Press Releases

CAMBRIDGE, Mass. , Feb. 18, 2020 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that
February 18, 2020
Displaying 11 - 15 of 15